XXII 22nd Century Group, Inc.
Cigarettes · Nasdaq · SEC CIK 1347858 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-15.5%
TTM net income YoY-79.5%
TTM EPS YoY135.6%
Revenue 3-yr CAGR-24.0%
Net income 3-yr CAGR—
Margins
Gross margin53.6%
Operating margin-76.7%
Net margin-80.0%
FCF margin-43.3%
EBITDA margin-73.7%
Returns
ROE-70.9%
ROA-43.8%
ROIC (approx.)-72.0%
Asset turnover0.55x
Leverage & solvency
Liabilities / assets31.2%
Debt / equity0.00x
Current ratio2.27x
Interest coverage-205.44x
Cash quality & payout
Operating cash flow / net income0.48x
Accruals ratio-22.7%
Payout ratio—
Capex / revenue4.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $4.76M | $2.86M | $4.11M | $3.54M | $4.01M | $4.08M | $5.96M | $4.02M |
| Cost of revenue | $1.66M | $1.62M | $1.93M | $1.88M | $2.56M | $2.86M | $2.88M | $3.09M |
| Gross profit | $3.10M | $1.24M | $2.18M | $1.66M | $1.45M | $1.22M | $3.07M | $927,000 |
| R&D expense | $233,000 | $295,000 | $285,000 | $105,000 | $193,000 | $227,000 | $162,000 | $218,000 |
| SG&A expense | $2.45M | $2.70M | $2.12M | $1.82M | $1.85M | $2.12M | $1.80M | $2.47M |
| Operating income | -$2.58M | -$3.29M | -$3.04M | -$2.80M | -$3.21M | -$2.98M | -$2.57M | -$4.09M |
| Interest expense | $17,000 | $17,000 | $11,000 | $12,000 | $534,000 | $351,000 | $558,000 | $266,000 |
| Pretax income | -$2.56M | -$3.27M | -$3.02M | -$2.78M | -$3.76M | -$3.33M | -$3.27M | -$4.24M |
| Income tax | — | — | — | $6,000 | $0 | -$34,000 | — | $3,000 |
| Net income | -$2.79M | -$3.35M | -$3.26M | -$2.81M | $5.49M | -$3.41M | -$4.33M | -$4.56M |
| EBITDA | -$2.46M | -$3.17M | -$2.93M | -$2.69M | -$3.09M | -$2.86M | -$2.45M | -$3.96M |
| EPS (basic) | -247.80 | -104.00 | -18.08 | — | 28,738.22 | -3,390.05 | -838.43 | — |
| EPS (diluted) | -247.80 | -104.00 | -18.08 | — | 28,738.22 | -3,390.05 | -838.43 | — |
| Weighted avg. shares (diluted) | 11,271 | 209,241 | 595,344 | — | 191 | 1,005 | 5,162 | — |
| Balance sheet | ||||||||
| Cash & equivalents | $3.91M | $6.06M | $9.54M | $7.15M | $4.85M | $3.08M | $1.13M | $4.42M |
| Receivables | $4.11M | $3.58M | $4.78M | $3.59M | $2.99M | $3.54M | $4.32M | $1.70M |
| Inventory | $4.36M | $4.54M | $4.35M | $4.33M | $2.91M | $2.50M | $2.56M | $2.02M |
| Current assets | $14.26M | $16.82M | $21.07M | $17.63M | $22.92M | $11.87M | $11.10M | $11.52M |
| PP&E, net | $2.81M | $2.60M | $2.37M | $2.44M | $2.45M | $2.57M | $2.66M | $2.77M |
| Intangibles | $5.64M | $6.06M | $6.14M | $6.22M | $6.21M | $6.43M | $6.11M | $5.72M |
| Total assets | $23.36M | $26.17M | $30.31M | $27.02M | $32.37M | $22.38M | $21.46M | $21.67M |
| Current liabilities | $6.29M | $6.45M | $7.91M | $7.27M | $10.54M | $15.39M | $16.40M | $9.96M |
| Short-term debt | — | — | — | — | — | $3.22M | $3.93M | $1.50M |
| Long-term debt | — | — | — | $708,000 | — | $3.22M | $3.93M | $5.17M |
| Total debt | — | — | — | $708,000 | — | $6.43M | $7.86M | $6.67M |
| Total liabilities | $7.28M | $7.53M | $9.09M | $8.53M | $11.26M | $16.75M | $17.83M | $17.66M |
| Shareholders' equity | $16.08M | $18.64M | $21.22M | $15.76M | $18.37M | $5.63M | $3.62M | $4.01M |
| Net debt | — | — | — | -$6.44M | — | $3.35M | $6.72M | $2.24M |
| Shares outstanding | 20,032 | 502,839 | 769,788 | 391 | — | 458,650 | 2.73M | 2,285 |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.54M | -$3.99M | -$3.10M | $2.75M | -$4.02M | -$3.48M | -$2.98M | -$4.40M |
| Capital expenditure | $341,000 | $331,000 | $40,000 | $16,000 | $6,000 | $29,000 | $10,000 | $0 |
| Free cash flow | -$1.89M | -$4.32M | -$3.14M | $2.73M | -$4.02M | -$3.51M | -$2.99M | -$4.40M |
| Investing cash flow | -$358,000 | -$310,000 | -$47,000 | -$655,000 | -$522,000 | $731,000 | -$59,000 | -$20,000 |
| Financing cash flow | -$245,000 | $812,000 | $5.55M | $209,000 | $6.30M | $4.70M | -$254,000 | $3.50M |
| Depreciation & amortization | $113,000 | $116,000 | $113,000 | $113,000 | $123,000 | $122,000 | $121,000 | $136,000 |
| Stock-based compensation | $377,000 | $270,000 | $238,000 | $196,000 | $92,000 | $107,000 | $26,000 | $147,000 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.